Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
BetaPro NatGas 2xBul	HNU	5. nov 2024	1.99	-7.87
BetaPro S&P500 -2xBr	HSD	5. nov 2024	16.17	-2.47
BetaPro S&P500 2x Bl	HSU	5. nov 2024	25.00	+2.42
BetaPro Slvr -2DlyBr	HZD	5. nov 2024	6.62	-0.90
BetaPro Slvr 2xDlyBl	HZU	5. nov 2024	31.40	+0.93
BetaPro60 DailyInvrs	HIX	5. nov 2024	25.54	0.00
BetaProCdnGldMn-2xBr	HGD	5. nov 2024	2.27	+0.89
BetaProCdnGldMnr2xBl	HGU	5. nov 2024	24.90	-1.15
BetaProNASDQ100 2xBl	HQU	5. nov 2024	22.35	+2.57
BetaProNatGas -2x Br	HND	5. nov 2024	103.54	+8.14
BetaProNSDQ100 -2xBr	HQD	5. nov 2024	11.30	-2.59
BetaProS&PTSX Engy2x	HEU	5. nov 2024	27.90	-0.11
BetaProS&PTSX60 2xBl	HXU	5. nov 2024	26.37	+1.19
BetaProS&PTSX60-2xBr	HXD	5. nov 2024	4.92	-1.20
BetaProS&PTSXEngy-2x	HED	5. nov 2024	4.13	+0.24
BetaProSP500 ST Futr	HUV	5. nov 2024	9.15	-5.86
BetaProSP500DlyInvrs	HIU	5. nov 2024	11.17	-1.11
BetaProSPTSX Fin -2x	HFD	5. nov 2024	6.70	-0.89
BetaProSPTSXFin 2xBl	HFU	5. nov 2024	29.48	+1.62
BeWhere Holdings Inc	BEW	5. nov 2024	0.83	-1.19
Big Banc Split Corp	BNK	5. nov 2024	12.05	-1.79
Big Banc Split Corp 8.40% PRF REDEEM 30/11/2026 CAD 10	BNK.PR.A	5. nov 2024	10.35	0.00
Big Pharma Split Corp	PRM	5. nov 2024	13.34	-0.82
Big Pharma Split Corp 5% PRF REDEEM 31/12/2027 CAD 10	PRM.PR.A	5. nov 2024	9.99	0.00
Big Ridge Gold Corp.	BRAU	5. nov 2024	0.11	-8.70
Big Rock Brewery Inc	BR	5. nov 2024	1.10	-3.51
Big Tree Carbon Inc	BIGT	5. nov 2024	0.02	0.00
BIGG Digital Assets Inc	BIGG	5. nov 2024	0.19	0.00
Bioasis Technologies Inc	BTI	5. nov 2024	0.01	0.00
BioNeutra Global Corp	BGA	5. nov 2024	0.03	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.